Four sequential experiments were performed in this investigation and collectively led to the conclusion that CD11b+ myeloid leukocytes bind Stx2 and act as the exclusive toxin carriers to the kidneys, resulting in lethal HUS in vivo. This evidence concerns the gene STX2 and hemolytic-uremic syndrome.